Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mehek Ningoo"'
Autor:
Francisco Fueyo-González, Guillermo Vilanova, Mehek Ningoo, Nada Marjanovic, Juan A. González-Vera, Ángel Orte, Miguel Fribourg
Publikováno v:
iScience, Vol 26, Iss 12, Pp 108491- (2023)
Summary: Foxp3 acetylation is essential to regulatory T (Treg) cell stability and function, but pharmacologically increasing it remains an unmet challenge. Here, we report that small-molecule compounds that inhibit TIP60, an acetyltransferase known t
Externí odkaz:
https://doaj.org/article/4de2a10881174d1782151cb6cdfb9242
Autor:
Francisco Fueyo-González, Mitchell McGinty, Mehek Ningoo, Lisa Anderson, Chiara Cantarelli, null Andrea Angeletti, Markus Demir, Inés Llaudó, Carolina Purroy, Nada Marjanovic, David Heja, Stuart C. Sealfon, Peter S. Heeger, Paolo Cravedi, Miguel Fribourg
Publikováno v:
Immunity
Type I interferons (IFNs) are pleiotropic cytokines with potent antiviral properties that also promote protective T cell and humoral immunity. Paradoxically, type I IFNs, including the widely expressed IFNβ, also have immunosuppressive properties, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::effbb2842e329cd204067d0afd31a53b
https://europepmc.org/articles/PMC8917088/
https://europepmc.org/articles/PMC8917088/
Publikováno v:
The Journal of Biological Chemistry
Transient receptor potential canonical type 5 (TRPC5) ion channels are expressed in the brain and kidney and have been identified as promising therapeutic targets whose selective inhibition can protect against diseases driven by a leaky kidney filter
Transient receptor potential canonical type 5 (TRPC5) channels are expressed in the brain and kidney, and have been identified as promising therapeutic targets whose selective inhibition can protect against diseases driven by a leaky kidney filter. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eda12e84f60bd21e0a8afcf3b1da6d55
https://doi.org/10.1101/2021.01.25.428089
https://doi.org/10.1101/2021.01.25.428089